XML 67 R58.htm IDEA: XBRL DOCUMENT v3.21.2
Schedule of Supplemental Balance Sheet Information Related to Operating and Financing Leases (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Lessee, Lease, Description [Line Items]    
Right-of-use assets, net [1] $ 3,499 $ 3,397
Machinery and equipment, net 2,918 $ 3,262
Operating and Financing Leases [Member]    
Lessee, Lease, Description [Line Items]    
Right-of-use assets, net 2,690  
Right-of-use lease liabilities, current 685  
Right-of-use lease liabilities, noncurrent 3,618  
Total operating lease liabilities 4,303  
Machinery and equipment 537  
Accumulated depreciation (309)  
Machinery and equipment, net 228  
Current liabilities 101  
Noncurrent liabilities 144  
Total financing lease liabilities $ 245  
Weighted average remaining lease term, Operating leases 5 years 6 months  
Weighted average remaining lease term, Financing leases 2 years 3 months 18 days  
Weighted average discount rate, Operating leases 11.16%  
Weighted average discount rate, Financing leases 11.55%  
[1] Oncocyte recorded certain right-of-use assets and liabilities for operating leases in accordance with ASC 842 (see Notes 3 and 10).